This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Audiocure Pharma Gmbh, Ellneuroxx, Ltd., Trommsdorff Gmbh & Co. Kg. Active years: 2001-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2025
Title: The Innovations of Hans Rommelspacher
Introduction
Hans Rommelspacher is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable polymorphic forms of compounds. With a total of 7 patents to his name, Rommelspacher's work has implications for the treatment of various medical conditions.
Latest Patents
One of his latest patents is focused on a stable polymorphic form of 6-fluoro-9-methyl-9H-β-carboline. This invention includes a method for preparing this crystalline polymorphic form and a pharmaceutical composition that incorporates it. The stable crystalline polymorphic form is intended for use in the treatment and/or prophylaxis of hearing damage, vertigo, or vestibular disorders. Another significant patent involves fluoro-9-methyl-β-carbolines, detailing their preparation and medical uses, along with pharmaceutical compositions containing these compounds.
Career Highlights
Throughout his career, Rommelspacher has worked with various companies, including Audiocure Pharma GmbH. His innovative approaches and research have positioned him as a key figure in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Rommelspacher has collaborated with notable coworkers such as Rudy Susilo and Lidia Wlodek. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Hans Rommelspacher's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact medical treatments and innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile